Nothing Special   »   [go: up one dir, main page]

IT1271088B - Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche - Google Patents

Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche

Info

Publication number
IT1271088B
IT1271088B ITMI942382A ITMI942382A IT1271088B IT 1271088 B IT1271088 B IT 1271088B IT MI942382 A ITMI942382 A IT MI942382A IT MI942382 A ITMI942382 A IT MI942382A IT 1271088 B IT1271088 B IT 1271088B
Authority
IT
Italy
Prior art keywords
hematopoietic cells
proliferation
differentiation
growth factor
hepatocyte growth
Prior art date
Application number
ITMI942382A
Other languages
English (en)
Inventor
Paolo Comoglio
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of ITMI942382A0 publication Critical patent/ITMI942382A0/it
Priority to ITMI942382A priority Critical patent/IT1271088B/it
Priority to CA002205914A priority patent/CA2205914C/en
Priority to AT95941620T priority patent/ATE225183T1/de
Priority to ES95941620T priority patent/ES2183890T3/es
Priority to US08/836,896 priority patent/US5968501A/en
Priority to EP95941620A priority patent/EP0793503B1/en
Priority to JP51657696A priority patent/JP3874024B2/ja
Priority to PCT/EP1995/004589 priority patent/WO1996015802A1/en
Priority to PT95941620T priority patent/PT793503E/pt
Priority to AU42996/96A priority patent/AU707259B2/en
Priority to DK95941620T priority patent/DK0793503T3/da
Priority to DE69528473T priority patent/DE69528473T2/de
Publication of ITMI942382A1 publication Critical patent/ITMI942382A1/it
Application granted granted Critical
Publication of IT1271088B publication Critical patent/IT1271088B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Si descrive l'uso del fattore di crescita degli epatociti per la preparazione dei medicamenti utili per indurre la proliferazione e la differenziazione di cellule emopoietiche, in particolare di progenitori di cellule emopoietiche multipotenti e eritroidi.
ITMI942382A 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche IT1271088B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI942382A IT1271088B (it) 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
JP51657696A JP3874024B2 (ja) 1994-11-24 1995-11-22 造血細胞の増殖および分化を誘導するための肝細胞増殖因子の使用
PT95941620T PT793503E (pt) 1994-11-24 1995-11-22 Uso do factor de crescimento dos hepatocitos para induzir a proliferacao e diferenciacao de celulas henatopoieticas
ES95941620T ES2183890T3 (es) 1994-11-24 1995-11-22 Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
US08/836,896 US5968501A (en) 1994-11-24 1995-11-22 Hepatocyte growth factor--induced proliferation and differentiation of erythroid cells
EP95941620A EP0793503B1 (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
CA002205914A CA2205914C (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
PCT/EP1995/004589 WO1996015802A1 (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
AT95941620T ATE225183T1 (de) 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
AU42996/96A AU707259B2 (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
DK95941620T DK0793503T3 (da) 1994-11-24 1995-11-22 Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
DE69528473T DE69528473T2 (de) 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942382A IT1271088B (it) 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche

Publications (3)

Publication Number Publication Date
ITMI942382A0 ITMI942382A0 (it) 1994-11-24
ITMI942382A1 ITMI942382A1 (it) 1996-05-24
IT1271088B true IT1271088B (it) 1997-05-26

Family

ID=11369904

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942382A IT1271088B (it) 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche

Country Status (12)

Country Link
US (1) US5968501A (it)
EP (1) EP0793503B1 (it)
JP (1) JP3874024B2 (it)
AT (1) ATE225183T1 (it)
AU (1) AU707259B2 (it)
CA (1) CA2205914C (it)
DE (1) DE69528473T2 (it)
DK (1) DK0793503T3 (it)
ES (1) ES2183890T3 (it)
IT (1) IT1271088B (it)
PT (1) PT793503E (it)
WO (1) WO1996015802A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004090121A2 (en) * 2003-04-08 2004-10-21 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
WO2006040615A2 (en) * 2003-06-11 2006-04-20 Jan Remmereit Differenciation of stem cells for therapeutic use
EP1722811B1 (en) * 2004-03-09 2007-11-07 Tohoku Technoarch Co., Ltd. Use of hepatocyte growth factor for promoting induction of vascular differentiation
JP4797186B2 (ja) * 2004-10-08 2011-10-19 剛史 汐田 末梢血中への造血幹細胞動員剤
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
US20160060601A1 (en) * 2013-04-17 2016-03-03 Nissan Chemical Industries, Ltd. Medium composition and method for producing red blood cells using same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
DE69130494T2 (de) * 1990-06-11 1999-07-08 Nakamura, Toshikazu, Fukuoka Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
KR0153009B1 (ko) * 1990-07-13 1998-10-15 카츄아 쇼노 티씨에프-ii의 아미노산 서열을 암호하는 dna를 함유한 플라스미드 형질전환세포 및 이것을 사용하여 생리 활성물질을 생산하는 방법
DE69230879T2 (de) * 1991-07-26 2000-08-03 Toray Industries, Inc. Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5599703A (en) * 1993-10-28 1997-02-04 The United States Of America As Represented By The Secretary Of The Navy In vitro amplification/expansion of CD34+ stem and progenitor cells

Also Published As

Publication number Publication date
DE69528473D1 (de) 2002-11-07
EP0793503A1 (en) 1997-09-10
EP0793503B1 (en) 2002-10-02
JPH10509951A (ja) 1998-09-29
DK0793503T3 (da) 2003-02-03
AU4299696A (en) 1996-06-17
ES2183890T3 (es) 2003-04-01
ATE225183T1 (de) 2002-10-15
DE69528473T2 (de) 2003-07-10
ITMI942382A0 (it) 1994-11-24
ITMI942382A1 (it) 1996-05-24
JP3874024B2 (ja) 2007-01-31
AU707259B2 (en) 1999-07-08
CA2205914C (en) 2009-04-07
US5968501A (en) 1999-10-19
CA2205914A1 (en) 1996-05-30
PT793503E (pt) 2003-02-28
WO1996015802A1 (en) 1996-05-30

Similar Documents

Publication Publication Date Title
AU6417886A (en) Heterocyclic compounds and and their preparation and use
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
DE69033700D1 (de) Il-11 aus säugetier
DE3590594T1 (it)
SE8604875L (sv) Nya naftalenderivat med retinal verkan, forfarande for framstellning derav och lekemedelskompositioner och kosmetiska kompositioner innehallande dessa
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
EG18379A (en) Novel pharmacological compounds
ES2194055T3 (es) Nuevo uso de prostaglandinas.
IT1271088B (it) Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
BR9611571B1 (pt) composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal.
ZA773259B (en) Improvements in or relating to methods for reducing the doses of biologically active substances while maintaining the biological effects
IT1252061B (it) Composizioni per uso dermatologico e cosmetico
IT8424002A0 (it) Composizione topica per modificare la velocita' di crescita di pelo stimolata da androgeni e uso della stessa
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
NO902104L (no) Kosmetisk blanding.
IT1255657B (it) Colture di tessuto di mucosa congiuntivale differenziata, procedimentoper la loro preparazione e supporti per il loro uso.
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
FR2657258B1 (it)
IT7827363A0 (it) Procedimento per produrre in parti di materia artificiale superfici insensibili all'uso.
DK0398669T3 (da) Kosmetisk præparat
IT1250647B (it) Uso di ammine organiche cicliche in composizioni dermatologiche
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
IT1194291B (it) Procedimento per la preparazione di antibiotici del gruppo antracicline con attivita' anti-cancro,e ceppo di microrganismi
IT9040036A0 (it) Flacone per la produzione e l'uso di preparati liofilizzabili

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971126